About IGF-1
Binds IGF-1R with high affinity, activating PI3K/Akt and MAPK pathways promoting protein synthesis, satellite cell activation, and glucose uptake. Much shorter half-life (~15 min) than the LR3 analog (~20-30 hr) due to binding protein interactions.
The native form of insulin-like growth factor 1, produced primarily by the liver in response to growth hormone stimulation. The primary mediator of GH effects on muscle growth, fat metabolism, and tissue repair. Distinct from IGF-1 LR3 (the extended long-acting analog already in catalog).
Research Areas
Regulatory & Evidence
Risk Profile
Moderate risk profile in research contexts. Review contraindications and administration guidelines before use.
Regulatory Status
- Availability Status
- Research Only
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.